Paper62814
Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
Price KE and 2 others. J Infect Dis, 1976. Cited by 88 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates. Papers, record 62814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62814
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Bacteria | Major topic |
| Kanamycin | Major topic |
| Acinetobacter | |
| Alcaligenes | |
| Butirosin Sulfate | |
| Dibekacin | |
| Drug Resistance, Microbial | |
| Enterobacteriaceae | |
| Flavobacterium | |
| Gentamicins | |
| Neomycin | |
| Paromomycin | |
| Pseudomonas | |
| Ribostamycin | |
| Staphylococcus | |
| Tobramycin |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40673769 | Externally validated population pharmacokinetics of amikacin and evaluation of dosage regimen based on achieved serum concentrations in neonates. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40673769 | PubMed |
| 40572734 | Impact of Dual Antibiotic Prophylaxis on 90-Day Surgical Site Infection Rates Following Posterior Spinal Fusion for Juvenile Scoliosis: A Single-Center Study of 296 Cases. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40572734 | PubMed |
| 29257114 | Amikacin: Uses, Resistance, and Prospects for Inhibition. | Molecules | 2017 | https://conductscience.org/library/papers/29257114 | PubMed |
| 7447431 | Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447431 | PubMed |
| 7419794 | Which aminoglycoside? | Intensive Care Med | 1980 | https://conductscience.org/library/papers/7419794 | PubMed |
| 7159071 | Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7159071 | PubMed |
| 7036923 | Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function. | Ann Surg | 1982 | https://conductscience.org/library/papers/7036923 | PubMed |
| 6994638 | Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6994638 | PubMed |
| 6775590 | UK31214, a new aminoglycoside and derivative of kanamycin B. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6775590 | PubMed |
| 6452572 | Inhibition of bacteriophage replication by extrachromosomal genetic elements. | Microbiol Rev | 1981 | https://conductscience.org/library/papers/6452572 | PubMed |
| 6289743 | Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6289743 | PubMed |
| 6272630 | Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6272630 | PubMed |
| 6264851 | Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6264851 | PubMed |
| 762403 | The increasing isolation of Serratia species from clinical specimens. | J Hyg (Lond) | 1979 | https://conductscience.org/library/papers/762403 | PubMed |
| 677859 | Surveillance of gentamicin-resistant gram-negative bacilli in a general hospital. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/677859 | PubMed |
| 626492 | Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/626492 | PubMed |
| 533263 | Amikacin pharmacokinetics in pediatric patients with malignancy. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/533263 | PubMed |
| 412464 | Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/412464 | PubMed |
| 387747 | Evolution of multiple-antibiotic-resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. | J Bacteriol | 1979 | https://conductscience.org/library/papers/387747 | PubMed |
| 374277 | [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin]. | Infection | 1979 | https://conductscience.org/library/papers/374277 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/62814
GET https://conductscience.org/api/papers/v1/62814/cited_by?page=2